Australia markets closed

Revolution Medicines, Inc. (RVMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
38.99-0.40 (-1.02%)
At close: 04:00PM EDT
38.99 +0.02 (+0.05%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.43B
Enterprise value 4.82B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.12k
Price/book (mrq)3.73
Enterprise value/revenue 1.06k
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.46
52-week change 350.83%
S&P500 52-week change 326.36%
52-week high 340.21
52-week low 315.44
50-day moving average 334.67
200-day moving average 329.28

Share statistics

Avg vol (3-month) 31.47M
Avg vol (10-day) 31.1M
Shares outstanding 5164.99M
Implied shares outstanding 6164.99M
Float 8161.17M
% held by insiders 12.37%
% held by institutions 198.78%
Shares short (30 Apr 2024) 412.53M
Short ratio (30 Apr 2024) 49.12
Short % of float (30 Apr 2024) 48.10%
Short % of shares outstanding (30 Apr 2024) 47.60%
Shares short (prior month 28 Mar 2024) 412M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-11,550.31%

Management effectiveness

Return on assets (ttm)-22.11%
Return on equity (ttm)-36.17%

Income statement

Revenue (ttm)4.57M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -522.04M
Net income avi to common (ttm)-484.27M
Diluted EPS (ttm)-3.84
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.7B
Total cash per share (mrq)10.32
Total debt (mrq)88.03M
Total debt/equity (mrq)5.10%
Current ratio (mrq)18.45
Book value per share (mrq)10.46

Cash flow statement

Operating cash flow (ttm)-448.74M
Levered free cash flow (ttm)-236.99M